Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Clin Genitourin Cancer. 2013 Jul 5;11(4):10.1016/j.clgc.2013.04.029. doi: 10.1016/j.clgc.2013.04.029

Figure 2.

Figure 2

Bone Mineral Density (BMD) Results. (A) Percentage Change From Baseline BMD in the Lumbar Spine. Note That the Data Points for Arms 2 and 3 at Month 0 and Month 6 are Grouped as Described in the Statistical Analysis for All Measured Sites. *Denotes That Arm 3 is Significantly Different From Baseline at 12 mo (P = .009), 18 mo (P = .043), and 24 mo (P = .044). (B) Percentage Change From Baseline BMD in the Femoral Neck. *Denotes That Arms 2 and 3 are Significantly Different From Baseline (P = .04). +Denotes That Arm 1 is Significantly Different From Arm 3 (P = .036). (C) Percentage Change From Baseline BMD in the Total Proximal Femur. *Denotes That Arm 1 is Significantly Different From Baseline (P = .047). +Denotes That Arm 1 is Significantly Different Compared With Arms 2 and 3 (P = .008). (D) Percentage Change From Baseline BMD in the Trochanter. +Denotes That Arm 1 is Significantly Different Compared With Arms 2 and 3 (P = .016). #Denotes That Arm 1 is Significantly Different Compared With Arm 2 (P = .026). ^Denotes That Arm 3 Is Significantly Different Compared With Arm 2 (P = .035)